Mutations in U2AF1 were first discovered in MDS, clonal hematopoietic stem-cell disorders that are characterized by deregulated, dysplastic blood cell formation and cytopenias19,21. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.